The FDA's Teeth Get Sharper
LCGC North America
Many readers who also subscribe to LCGC's sister publication, Spectroscopy, may have read industry expert Bob McDowall's November 2009 column on the new posture of the U.S. FDA ("The Tiger Has Sharp New Teeth," Spectroscopy 24[11], 23–29 [2009]). As he saw it, "The new FDA Commissioner wants a strong FDA and is backing her words with action."
Many readers who also subscribe to LCGC's sister publication, Spectroscopy, may have read industry expert Bob McDowall's November 2009 column on the new posture of the U.S. FDA ("The Tiger Has Sharp New Teeth," Spectroscopy24[11], 23–29 [2009]). As he saw it, "The new FDA Commissioner wants a strong FDA and is backing her words with action." In light of the news coming out of Washington at the time of this writing, he may have been more correct than he imagined. Here we are just a few months later, and the internet, cable news networks, and radio talk shows are all abuzz with the latest initiative put in place by the FDA and its commissioner, Dr. Margaret Hamburg, to limit the amount of sodium Americans consume.
David Walsh
According to the Washington Post (4/20/10), "The effort would eventually lead to the first legal limits on the amount of salt allowed in processed foods," and would also lead to an unprecedented show of power on the part of not only the FDA, but the federal government in general. And while the left may cheer such a move as protecting public health and libertarians and the right may express shock at such a chilling invasion of personal freedoms, one is left to wonder what the implications of such a posture on the part of the FDA may be for the separations community in particular and laboratories in general.
At the very least, it seems to indicate that regulations such as the postinspection response program described by McDowall (initiated on September 15, 2009) will be the norm rather than the exception. And new requirements such as complete responses to 483 observations within 15 working days could be a harbinger of further regulations to come for laboratories in the U.S., rather than a one-time move.
It will be interesting to see how this initiative plays out in the realm of public opinion, where the FDA will either be emboldened to pass further regulations and restrictions (sharpening the tiger's teeth further) or chastened by public outcry. One thing is certain, we will all be hearing more on this in the weeks and months to come.
David Walsh
Editor-in-Chief
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
